How Coca-Cola shaped obesity science and policy in China
Susan Greenhalg is a research professor of chinese society in Harvard ’s department of anthropology - not a natural fit for a medical journal you may think, but recently she has been looking at the influence of Coca Cola on obesity policy in China.
She has written up her investigation in an article published on bmj.com this week, and joins us in the podcast to tal k about why a communist country would embrace a message from an icon of capitalism, and what attitudes toward financial conflicts of interest exist in the country.
Read the full feature:
https://www.bmj.com/content/364/bmj.k5050
Accompanying editorial:https:...
Source: The BMJ Podcast - January 9, 2019 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
How Coca-Cola shaped obesity science and policy in China
Susan Greenhalg is a research professor of chinese society in Harvard ’s department of anthropology - not a natural fit for a medical journal you may think, but recently she has been looking at the influence of Coca Cola on obesity policy in China.
She has written up her investigation in an article published on bmj.com this week, and joins us in... (Source: The BMJ Podcast)
Source: The BMJ Podcast - January 9, 2019 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
What's on the Horizon For CLL
Jennifer Brown, M.D., Director of the CLL Center of the Division of Hematologic Malignancies at Dana-Farber Cancer Institute and an Associate Professor of Medicine at Harvard Medical School in Boston,...
Author: imedex
Added: 11/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 28, 2018 Category: Cancer & Oncology Source Type: podcasts
Whats On The Horizon For CLL
Jennifer Brown, M.D., Director of the CLL Center of the Division of Hematologic Malignancies at Dana-Farber Cancer Institute and an Associate Professor of Medicine at Harvard Medical School in Boston,...
Author: imedex
Added: 11/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 28, 2018 Category: Cancer & Oncology Source Type: podcasts
The Role Of MRD In CLL
Jennifer Brown, M.D., Director of the CLL Center of the Division of Hematologic Malignancies at Dana-Farber Cancer Institute and an Associate Professor of Medicine at Harvard Medical School in Boston,...
Author: imedex
Added: 11/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 28, 2018 Category: Cancer & Oncology Source Type: podcasts
Prophylaxis With Pi3 Kinase Inhibitors
Jennifer Brown, M.D., Director of the CLL Center of the Division of Hematologic Malignancies at Dana-Farber Cancer Institute and an Associate Professor of Medicine at Harvard Medical School in Boston,...
Author: imedex
Added: 11/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 28, 2018 Category: Cancer & Oncology Source Type: podcasts
Pi3 Kinase Inhibitors, Idelalisib, Duvelisib, & amp; Copanlisib
Jennifer Brown, M.D., Director of the CLL Center of the Division of Hematologic Malignancies at Dana-Farber Cancer Institute and an Associate Professor of Medicine at Harvard Medical School in Boston,...
Author: imedex
Added: 11/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 28, 2018 Category: Cancer & Oncology Source Type: podcasts
Pi3 Kinase Inhibitors Autoimmune Toxicity
Jennifer Brown, M.D., Director of the CLL Center of the Division of Hematologic Malignancies at Dana-Farber Cancer Institute and an Associate Professor of Medicine at Harvard Medical School in Boston,...
Author: imedex
Added: 11/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 28, 2018 Category: Cancer & Oncology Source Type: podcasts
Duvelisib: New Treatment For Relapse Refractory CLL
Jennifer Brown, M.D., Director of the CLL Center of the Division of Hematologic Malignancies at Dana-Farber Cancer Institute and an Associate Professor of Medicine at Harvard Medical School in Boston,...
Author: imedex
Added: 11/28/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 28, 2018 Category: Cancer & Oncology Source Type: podcasts
Targeting Vulnerabilities Arising from Dysregulated Histone Demethylase Function in Kidney Cancer
Abhishek A. Chakraborty Instructor in Medicine Department of Medical Oncology Laboratory of William Kaelin Dana-Farber Cancer Institute Harvard Medical School discusses Targeting ...
Author: kidneycancer
Added: 11/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 6, 2018 Category: Cancer & Oncology Source Type: podcasts
A Secreted PD-L1 Splice Variant that Covalently Dimerizes and Mediates Immunosuppression
Kathleen Mahoney, M.D., Ph.D. Instructor of Medicine, Harvard Medical School Attending, Beth Israel Deaconess Medical Center Research Fellow, Dana Farber Cancer Institute discusse...
Author: kidneycancer
Added: 11/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 6, 2018 Category: Cancer & Oncology Source Type: podcasts
Laparoscopic Vs Robotic Radical Nephrectomy: What are the Costs and Benefits?
Steven L. Chang, MD, MS Assistant Professor of Surgery, Harvard Medical School Surgical Oncologist, Dana-Farber Cancer Institute Associate Surgeon, Division of Urology, Brigham and Womens Hospital d...
Author: kidneycancer
Added: 11/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - November 5, 2018 Category: Cancer & Oncology Source Type: podcasts
Explore the Synaptome with Seth Grant (BS 150)
Seth Grant (click image to play interview)
Dr. Seth Grant, director of the Genes To Cognition project in the UK, has been studying the molecular biology of the synapse for decades. This month marks his fourth appearance on Brain Science (BS 150). In his latest interview we discuss the findings of his latest paper in Neuron, and he also provides an overview of how this paper fits into his larger body of work. Longtime listeners will appreciate this update, but the material is also accessible to new listeners of all backgrounds.In earlier work Grant and his team discovered that vertebrate sy...
Source: the Brain Science Podcast and Blog with Dr. Ginger Campbell - October 26, 2018 Category: Neuroscience Authors: Ginger Campbell, MD Tags: Brain Evolution Brain Research Interviews learning Memory Neuroscience Podcast Show Notes Source Type: podcasts
Future treatment combinations for myeloma
Multiple myeloma (MM) therapy has evolved rapidly in recent years, and is showing no sign of slowing. Here, Kenneth Anderson, MD, from Harvard Medical School, Boston, MA, discusses interesting future ...
Author: VJHemOnc
Added: 10/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 10, 2018 Category: Cancer & Oncology Source Type: podcasts
The counter intuitive effect of open label placebo
Ted Kaptchuk, professor of medicine at Harvard Medical school - and leading placebo researcher, has just published an analysis on bmj.com describing the effect of open label placebo - placebos that patient's know are placebos, but still seem to have some clinical effect.
Ted joins us to speculate about what's going on in the body, what this means... (Source: The BMJ Podcast)
Source: The BMJ Podcast - October 6, 2018 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
